Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping: an Umbrella Phase II Exploratory Clinical Study
Latest Information Update: 28 Mar 2025
At a glance
- Drugs Adebrelimab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Retlirafusp alfa (Primary) ; Rivoceranib (Primary) ; SHR-A1904 (Primary) ; Trastuzumab rezetecan (Primary) ; Zolbetuximab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 28 Mar 2025 New trial record